Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

18.97
Delayed Data
As of Feb 12
 +0.37 / +1.99%
Today’s Change
17.76
Today|||52-Week Range
116.75
-45.80%
Year-to-Date

Today’s Trading

Previous close18.60
Today’s open18.87
Day’s range17.80 - 19.18
Volume1,301,673
Average volume (3 months)1,778,585
Market cap$726.9M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-60.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales139.29
Price/Book1.94

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...+0.06+0.32%
ZIOPZIOPHARM Oncology In...+0.10+1.82%
RGENRepligen Corp+1.24+5.71%
CLLSCellectis SA+0.15+0.78%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)-$2.43
Annual revenue (last year)$13.6M
Annual profit (last year)-$160.0M
Net profit margin-1,174.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Chief Financial Officer, Secretary &
Executive VP
Erle T. Mast
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers